Best Profit Opportunities

trading strategies

How to Make Profitable Earnings Season Trades Every Time

When you're trading options, getting on the "right side" of the trade simply means going long with calls on a stock that's going up, and short with puts on a stock that's headed down.

But earnings season really increases the stakes and the intensity of trading. Options premiums can fluctuate widely going into an earnings announcement, and things can get really interesting once the announcement is made, gapping up if the results are favorable, and down if they aren't.

Figuring out where these stocks will go so you can trade the appropriate options contracts would be one of trading's biggest challenges…

…if you had to concern yourself with it at all.

Today, I'm going to make it all easier for you, and show you how you can make money without having to guess where the stock is going after earnings announcements.

Trading doesn't get much easier than that, and earnings season is just about to get into full swing, so you'll be able to make some serious money over the next few weeks.

Let's get started...


The Best Stock to Buy if Hillary Clinton Becomes President

Right now, investors want to know what the best stock to buy is if Hillary Clinton becomes president of the United States.

That's because as of April 11, Clinton was favored by 29 points against Donald Trump in a recent poll.

While November is still off in the distance, we found a stock to invest in that could skyrocket if Clinton is elected. In fact, investors could net gains as high as 94%...

penny stocks

The 3 Best Penny Stocks to Buy and Hold in 2016

Penny stocks can be worthwhile investments… you just have to know where to look. We've identified three of the top penny stock investments to have right now…

One is an upstart bionics company that's developing cutting-edge exoskeleton technology…

Another is an energy company that could save the entire struggling coal industry…

The last one is a biotech company who's vaccine creation technology could disrupt an entire industry...


How to Protect Your Biotech Profits from This Legal Limbo

Gilead Sciences Inc.'s Sovaldi was a real breakthrough in the fight against the chronic liver disease hepatitis C (HCV). The condition may show no symptoms for years after initial infection but can slowly become debilitating.

Hepatitis C affects as many as 200 million people worldwide, and before Sovaldi, the approved drug regimen could treat only about 50% of cases and could cause serious side effects. Treatment was generally long – 24 to 48 weeks – and arduous.

Sovaldi, on the other hand, could cure more than 90% of cases in a matter of weeks at a cost, in the United States, of around $94,000. The pricing caused controversy, but the drug proved transformative for HCV patients, their families, and doctors.

Sovaldi also proved a huge windfall for investors when it received FDA approval in 2013 and entered the pharmaceutical marketplace the following year.

So far, Gilead shareholders have seen a 2:1 split, several dividend payouts, and gains of more than 155% since 2013. Sales of Sovaldi and Gilead's other HCV drug, Harvoni, topped $12.5 billion in 2015 alone.

There's just one big, expensive problem...

Global Markets

The Opportunity in the Eurozone's €650 Billion Leak

A funny thing happened while central banks were racing to make money cheap as free…

U.S. bank loan and deposit growth continues to go bonkers at annual growth rates of more than 8% for loans and around 6% for deposits.

Across the Atlantic, where negative-interest-rate policy (NIRP) is an ugly reality, loan and deposit growth in Europe is near zero – and that's in spite of the fact that Mario Draghi and his merry band of central bankers have thrown everything but the kitchen sink at their system to try to get it to grow.

But Draghi & Co. don't seem to realize their actions are killing Europe's markets while propping ours up.

It's going to end badly for the Europeans, but this insanity tends to create tremendous opportunities in American markets...

How to Invest

Profits Start on November 1 – Mark Your Calendar

As much as it pains me to contribute to the thousands of articles mentioning Donald Trump, this one is different…

It's different because I'm going to show you exactly how you can cash in on a concrete pattern, going back three-quarters of a century, which appears across the markets during the "election cycle," or the last two years of every American presidency.

No matter what "The Donald" says or does, no matter who wins, this event has offered savvy investors clockwork profits, and it will do the same for us, too, so it's important to start getting ready now.

Have a look at this chart and you'll see what I mean...

Tech Investing

Your High-Profit Guide to the New "Convergence Economy"

By any measure, we've experienced an extraordinary bull run, with the S&P 500 soaring as high as 2,134.72 since it bottomed out at 676.53 on March 9, 2009.

But the real story is in the catalysts that led the markets to better than triple over that relatively short time – the story beyond quantitative easing, cheap-as-free money, and tax breaks.

Rather, these extraordinary gains have come from a group of "hot spots" that have given rise to the creation of an entirely new economy.

Many so-called "experts" haven't even realized that this phenomenon exists yet, but our position – on its leading edge – has given us gain after triple-digit gain since 2012, with profits of more than 130% on Avago Technologies and more than 612% on Ambarella.

We've done well already, but – as you're about to see during this interview with our tech expert, Michael Robinson – this radical new economy has trillions in upside remaining.

Let's look at where those profits will come from in the weeks ahead...


Apple Stock (Nasdaq: AAPL): Everything You Need to Know

AAPL stock kicked off its first day of trading as part of the Dow Jones on Thursday, March 19th. There's one question on investors' minds – will the inclusion help or hurt the most valuable tech company in the world?

Learn more about Apple stock, including information on the Apple Watch's profit margin and the future of Apple TV.

Global Investing

Follow Africa's Richest Man Into One of the Best Profit Opportunities on Earth

Aliko Dangote is the richest man you've never heard of.

The 56-year old native of Kano, Nigeria is a self-made business magnate, with a net worth of more than $16 billion.

With boom times ahead for Africa, Dangote is leading the continent's headlong charge into infrastructure building and resource exploration.

A person of vision and drive, he's well suited for the unfolding boom, and all the opportunity it offers.

As the African Century moves into its second decade, Dangote is still very bullish on Africa– making – and keeping – most of his fortune there.

To continue reading, please click here...